Penile Cancer Clinical Trials in Georgia

Cancer Type = Penile Cancer

Cancer Type = Penile Cancer

There are currently 3 active Penile Cancer clinical trials in Georgia.
1.
A Phase II Study of Nivolumab Combined with Ipilimumab for Patients with Advanced Rare Genitourinary Tumors
Cancer Type
Adrenal Cancer, Bladder Cancer, Germ Cell Tumor, Penile Cancer, Prostate Cancer
NCI ID
NCT03333616
Protocol IDs
17-423
NCI-2018-00182
2.
InPACT- International Penile Advanced Cancer Trial (International Rare Cancers Initiative Study)
Cancer Type
Penile Cancer
NCI ID
NCT02305654
Protocol IDs
EA8134
EA8134
NCI-2016-01502
EA8134
3.
Phase II Trial of Pembrolizumab for Advanced Penile Squamous Cell Carcinoma following Previous Chemotherapy
Cancer Type
Penile Cancer
NCI ID
NCT02837042
Protocol IDs
UAB15107
NCI-2018-00125
Georgia CORE

 

Hearts and Minds Dedicated to Improving Cancer Care

Georgia CORE is a public-private partnership that creates collaboration among the state’s cancer organizations and institutions to connect more Georgians to quality, personalized cancer care. We welcome you to this one-of-a-kind online information center for all things related to cancer and survivorship care in Georgia.